ArticleBDJ open2025
The cross-cultural adaptation and psychometric evaluation of a Chinese version of the postoperative symptom severity (PoSSe) scale.
Article in BDJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe postoperative symptom severity (PoSSe) scale, which was developed in the UK, measures the impact of postoperative morbidity on patients' quality of life after lower third molar surgery. It has recently been used in Chinese populations but without having been adapted and validated for these populations. The aim of this study was to cross-culturally adapt and psychometrically evaluate a Chinese version (Simplified Chinese) of the PoSSe scale for applications in third molar surgery in Chinese patient populations.
methodsWe employed a rigorous multi-step cross-cultural adaptation process, including forward and backward translation followed by pilot testing, where participants documented the relevance and ease of understanding of the PoSSe items. The psychometric evaluation of the final Chinese version took place in a sample of 101 patients undergoing lower third molar surgery in Tianjin, China. Cronbach's Alpha (α) coefficient was calculated for the reliability evaluation, while the Spearman correlation coefficient (r
resultsThe PoSSe scale demonstrated excellent internal consistency (Cronbach's α = 0.80 for the whole sample; α = 0.80 among patients with bone removal during surgery; α = 0.81 among patients without bone removal during surgery). For validity assessment, PoSSe scores had statistically significant associations with the extent of surgical trauma (osteotomy and duration of surgery), self-reported pain and clinically assessed trismus. The strength of these associations varied between the two groups (with and without bone removal during surgery) in the expected direction. The results suggest that the Chinese version of the PoSSe scale has acceptable linguistic clarity, cultural relevance, and context appropriateness, showing excellent internal consistency and validity and can be confidently used for clinical and research applications in Chinese patient populations.
conclusionsThe PoSSe scale has been successfully cross-culturally adapted for postoperative use among Chinese patients undergoing third molar surgery and demonstrated successful psychometric assessment for its reliability and validity, which allows future informative studies in China, also in terms of comparison across countries involving China that could assess the cultural equivalence of the measure.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.